Tuesday, April 07, 2020

A second potential COVID-19 vaccine is entering human testing

Good news! Now we have to finally update and expedite the outdated FDA approval procedures etc.. Using synthesized and optimized plasmids seems to be a very promising approach!

" ... optimized DNA plasmids, which are small circles of double-stranded DNA that are synthesized or reorganized by a computer sequencing technology and designed to produce a specific immune response in the body ..."

A second potential COVID-19 vaccine, backed by Bill and Melinda Gates, is entering human testing | TechCrunch: A new COVID-19 vaccine candidate is entering Phase 1 clinical human testing today, after the U.S. Food and Drug Administration (FDA) accepted an application from Inovio Pharmaceuticals under the regulator’s Investigational New Drug program. Inovio plans to inject its first volunteer test subj…

Inovio Pharmaceuticals, Inc. - INOVIO Initiates Phase 1 Clinical Trial Of Its COVID-19 Vaccine and Plans First Dose Today: INOVIO Initiates Phase 1 Clinical Trial Of Its COVID-19 Vaccine and Plans First Dose Today April 06, 2020 - Up to 40 Healthy Volunteers To Participate at Two Trial Locations - Preclinical Animal Studies Show Promising Immune Responses - Rapid Advancement Possible Through a Global Coalition of Collaborators, Partners, and Funders


No comments: